Ventris Medical
Brenda Rodriguez, MS, MBA, CQA, currently serves as Sr Quality Manager at Ventris Medical, a position held since February 2023. Previously, Brenda held the role of Program Manager - Quality Systems at Bachem from March 2020 to February 2023. With a strong foundation in quality analysis, Brenda worked as a Quality Analyst at Edwards Lifesciences and as a Quality Assurance Specialist at Kite Pharma. Experience as a QA Specialist at Nitto Avecia Pharma Services involved conducting internal audits against ISO 13485:2003 standard and managing client inspections. Additionally, Brenda served as Quality Analyst II at Baxalta, overseeing nonconformance investigations and preparing management metrics, while earlier experience at Baxter International Inc. focused on raw materials disposition and nonconformance investigations. Educational background includes an MBA with a dual degree in Biotechnology from California State University Channel Islands Extended University and a BS in Biological Sciences from the University of California, Santa Barbara.
This person is not in any teams
Ventris Medical
It’s the Ventris focus on quality, donor selection, tissue recover, and processing protocols that sets us apart. The company is dedicated to providing products that adhere to the strictest current tissue banking and processing standards, with the ultimate goal of an exceptional outcome for the patient. Our line of human allograft products is regulated by the FDA Center for Biologics Evaluation and Research (CBER), which regulates human cells, tissues, and cellular and tissue-based products (HCT/Ps). Ventris adheres to Current Good Tissue Practices, focusing extensively on donor eligibility and the recovery process. Ventris Allograft products are regulated under 21 CFR Part 1270 and 21 CFR Part 1271 and Section 361 of the Public Health Services Act.